Katka Szilagyi

725 citations
7 papers · 536 indexed · 1 hit paper · h-index 5

Katka Szilagyi

6 papers receiving 530 citations

Hit Papers

The CD47‐SIRPα signaling axis as an innate immune checkpo...4212017202620202023100200300400

Peers

Katka Szilagyi
Comparison fields: 5 of 71
  • Immunology 394
  • Oncology 143
  • Immunology and Allergy 17
  • Molecular Biology 171
  • Cancer Research 34
Replace Rens Braster with:
Rens Braster Netherlands
Valeria Runza Germany
Huaijian Guo Canada
Atsuya Nobumoto Japan
Nakayuki Honma Japan
Belal Chaudhary United Kingdom
Daisuke Ito Japan
Gang Xue China
Sonya James United Kingdom
Marina Kovaleva United Kingdom
Katka Szilagyi relative to Rens Braster Netherlands Rens Braster's profile →
Citations per field
00.5×1.5×2.4×
Rens Braster · 1×
Citations per year

Countries citing papers authored by Katka Szilagyi

Since Specialization
Citations

This map shows the geographic impact of Katka Szilagyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katka Szilagyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katka Szilagyi more than expected).

Fields of papers citing papers by Katka Szilagyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katka Szilagyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katka Szilagyi. The network helps show where Katka Szilagyi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katka Szilagyi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katka Szilagyi Line = papers co-authored together Katka Szilagyi links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancerbreakdown →
2017421
2 201676
3
Role of Inflammation in Development of Atherosclerosis
20160
4 201511
5 201519
6 20141
7 20148

About Katka Szilagyi

Katka Szilagyi is a scholar working on Immunology, Immunology and Allergy and Neurology, having authored 7 papers that have together received 536 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Blood properties and coagulation (1 paper), Cell Adhesion Molecules Research (1 paper), Immune responses and vaccinations (1 paper), Polysaccharides and Plant Cell Walls (1 paper), Caveolin-1 and cellular processes (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Immunology (394 citations), Oncology (143 citations) and Immunology and Allergy (17 citations). Katka Szilagyi has collaborated with scholars based in Netherlands, Austria and France. Frequent co-authors include Timo K. van den Berg, Hanke L. Matlung, Neil Barclay, Taco W. Kuijpers, Dieke J. van Rees, Sigrid E.M. Heinsbroek, Menno P.J. de Winther, Kaan Boztuǧ, Saskia van der Velden and Elisabeth Förster‐Waldl. Their work appears in journals such as Immunological Reviews, Cardiovascular Research and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026